4//SEC Filing
Trius Therapeutics Inc 4
Accession 0001209191-13-030218
CIK 0001356857operating
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:49 PM ET
Size
5.6 KB
Accession
0001209191-13-030218
Insider Transaction Report
Form 4
Prokocimer Philippe
Chief Medical Officer
Transactions
- Sale
Common Stock
2013-06-03$7.75/sh−2,000$15,500→ 84,022 total(indirect: By Trust)
Holdings
- 10,865
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012
- [F2]Includes 436 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/20/13.
Documents
Issuer
Trius Therapeutics Inc
CIK 0001356857
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001356857
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:49 PM ET
- Size
- 5.6 KB